Vaxcyte IncNASDAQ:PCVX
- LAST PRICE45.4800
- TODAY'S CHANGE (%)0.2800 (0.6195%)
- Bid / Lots43.2500/ 1
- Ask / Lots46.0000/ 1
- Open / Previous Close45.2600 / 45.2000
- Day Range
- 52 Week Range
- Volume414,759
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PCVX |
|---|---|---|
| 09:32 ET | 2855 | 45.185 |
| 09:33 ET | 100 | 44.765 |
| 09:35 ET | 200 | 44.875 |
| 09:37 ET | 2771 | 44.985 |
| 09:42 ET | 200 | 44.955 |
| 09:44 ET | 600 | 45.1 |
| 09:46 ET | 1900 | 45.055 |
| 09:48 ET | 6330 | 45 |
| 09:50 ET | 300 | 44.94 |
| 09:51 ET | 2520 | 44.93 |
| 09:53 ET | 3741 | 44.96 |
| 09:55 ET | 600 | 44.875 |
| 09:57 ET | 1553 | 44.81 |
| 10:00 ET | 1401 | 44.92 |
| 10:02 ET | 1249 | 45.08 |
| 10:04 ET | 100 | 45.09 |
| 10:06 ET | 1300 | 44.96 |
| 10:08 ET | 872 | 45.09 |
| 10:11 ET | 2831 | 45.07 |
| 10:13 ET | 1800 | 45.01 |
| 10:15 ET | 300 | 45.08 |
| 10:18 ET | 600 | 45.12 |
| 10:20 ET | 513 | 45.23 |
| 10:22 ET | 100 | 45.14 |
| 10:24 ET | 200 | 45.095 |
| 10:26 ET | 400 | 44.995 |
| 10:27 ET | 1207 | 45 |
| 10:29 ET | 352 | 44.995 |
| 10:31 ET | 430 | 45 |
| 10:33 ET | 1010 | 45.1 |
| 10:38 ET | 700 | 45 |
| 10:40 ET | 200 | 45 |
| 10:42 ET | 400 | 45.06 |
| 10:44 ET | 1100 | 45.13 |
| 10:45 ET | 1800 | 45.13 |
| 10:47 ET | 100 | 45.14 |
| 10:49 ET | 600 | 45.09 |
| 10:51 ET | 1200 | 45.165 |
| 10:54 ET | 500 | 45.07 |
| 10:56 ET | 100 | 45.01 |
| 10:58 ET | 912 | 45.06 |
| 11:00 ET | 100 | 45.01 |
| 11:03 ET | 200 | 45.105 |
| 11:05 ET | 100 | 45.145 |
| 11:09 ET | 200 | 45.12 |
| 11:12 ET | 200 | 45.145 |
| 11:16 ET | 100 | 45.1 |
| 11:18 ET | 300 | 45.04 |
| 11:20 ET | 1596 | 44.97 |
| 11:21 ET | 2235 | 44.97 |
| 11:23 ET | 203 | 45 |
| 11:25 ET | 400 | 45.06 |
| 11:30 ET | 1000 | 44.97 |
| 11:32 ET | 200 | 44.995 |
| 11:34 ET | 1470 | 45.12 |
| 11:36 ET | 400 | 45.04 |
| 11:38 ET | 100 | 45.04 |
| 11:43 ET | 600 | 44.95 |
| 11:45 ET | 1600 | 44.96 |
| 11:48 ET | 817 | 45.045 |
| 11:50 ET | 400 | 44.98 |
| 11:52 ET | 100 | 44.99 |
| 11:54 ET | 300 | 45.027 |
| 11:56 ET | 200 | 44.975 |
| 11:57 ET | 500 | 44.975 |
| 11:59 ET | 1500 | 45.005 |
| 12:03 ET | 200 | 45 |
| 12:06 ET | 695 | 45 |
| 12:08 ET | 4266 | 45 |
| 12:10 ET | 300 | 45.1 |
| 12:12 ET | 1800 | 45.06 |
| 12:14 ET | 200 | 45.075 |
| 12:17 ET | 461 | 45.02 |
| 12:19 ET | 1257 | 44.85 |
| 12:21 ET | 600 | 44.805 |
| 12:24 ET | 600 | 44.685 |
| 12:26 ET | 200 | 44.675 |
| 12:28 ET | 800 | 44.675 |
| 12:30 ET | 1100 | 44.78 |
| 12:32 ET | 1212 | 44.69 |
| 12:33 ET | 2600 | 44.795 |
| 12:35 ET | 200 | 44.795 |
| 12:37 ET | 300 | 44.795 |
| 12:39 ET | 1444 | 44.77 |
| 12:42 ET | 5540 | 45 |
| 12:44 ET | 2100 | 44.99 |
| 12:46 ET | 1375 | 45.17 |
| 12:48 ET | 300 | 45.185 |
| 12:50 ET | 100 | 45.25 |
| 12:51 ET | 500 | 45.17 |
| 12:53 ET | 200 | 45.24 |
| 12:55 ET | 100 | 45.205 |
| 12:57 ET | 600 | 45.32 |
| 01:00 ET | 1492 | 45.27 |
| 01:02 ET | 600 | 45.39 |
| 01:04 ET | 400 | 45.34 |
| 01:06 ET | 100 | 45.3 |
| 01:08 ET | 100 | 45.3 |
| 01:09 ET | 400 | 45.36 |
| 01:11 ET | 100 | 45.32 |
| 01:15 ET | 800 | 45.24 |
| 01:18 ET | 400 | 45.145 |
| 01:20 ET | 1040 | 45.2 |
| 01:22 ET | 700 | 45.21 |
| 01:24 ET | 300 | 45.09 |
| 01:27 ET | 700 | 45 |
| 01:29 ET | 3500 | 45.12 |
| 01:31 ET | 2100 | 45 |
| 01:33 ET | 1593 | 44.815 |
| 01:36 ET | 1308 | 44.785 |
| 01:38 ET | 1300 | 44.92 |
| 01:40 ET | 4388 | 45.13 |
| 01:42 ET | 200 | 45.11 |
| 01:44 ET | 778 | 44.92 |
| 01:45 ET | 1100 | 44.9 |
| 01:47 ET | 188 | 44.77 |
| 01:49 ET | 1288 | 44.89 |
| 01:51 ET | 1900 | 44.74 |
| 01:58 ET | 569 | 44.895 |
| 02:00 ET | 100 | 44.855 |
| 02:02 ET | 500 | 44.9 |
| 02:03 ET | 1513 | 44.98 |
| 02:05 ET | 4800 | 45.14 |
| 02:07 ET | 407 | 45.245 |
| 02:09 ET | 100 | 45.275 |
| 02:12 ET | 700 | 45.07 |
| 02:16 ET | 600 | 45.145 |
| 02:18 ET | 200 | 45.2 |
| 02:20 ET | 100 | 45.145 |
| 02:23 ET | 550 | 44.99 |
| 02:27 ET | 200 | 45.06 |
| 02:30 ET | 663 | 45 |
| 02:32 ET | 984 | 45.1 |
| 02:34 ET | 900 | 45.22 |
| 02:36 ET | 931 | 45.09 |
| 02:41 ET | 300 | 45.09 |
| 02:43 ET | 617 | 45.1 |
| 02:45 ET | 1000 | 45.09 |
| 02:50 ET | 200 | 45.105 |
| 02:54 ET | 300 | 45.14 |
| 02:56 ET | 200 | 45.155 |
| 02:57 ET | 300 | 45.17 |
| 02:59 ET | 600 | 45.21 |
| 03:01 ET | 700 | 45.33 |
| 03:03 ET | 300 | 45.22 |
| 03:06 ET | 100 | 45.165 |
| 03:08 ET | 100 | 45.01 |
| 03:10 ET | 500 | 45.035 |
| 03:12 ET | 600 | 45.06 |
| 03:14 ET | 900 | 45.14 |
| 03:15 ET | 100 | 45.19 |
| 03:17 ET | 100 | 45.15 |
| 03:19 ET | 100 | 45.15 |
| 03:21 ET | 1000 | 45.22 |
| 03:24 ET | 200 | 45.23 |
| 03:26 ET | 643 | 45.17 |
| 03:28 ET | 400 | 45.21 |
| 03:30 ET | 500 | 45.28 |
| 03:32 ET | 200 | 45.33 |
| 03:35 ET | 1000 | 45.335 |
| 03:37 ET | 100 | 45.335 |
| 03:39 ET | 1200 | 45.42 |
| 03:42 ET | 100 | 45.42 |
| 03:44 ET | 1000 | 45.44 |
| 03:48 ET | 700 | 45.475 |
| 03:50 ET | 1591 | 45.56 |
| 03:51 ET | 1200 | 45.58 |
| 03:53 ET | 2458 | 45.59 |
| 03:55 ET | 2200 | 45.57 |
| 03:57 ET | 3773 | 45.46 |
| 04:00 ET | 123641 | 45.48 |
Today
Vaxcyte to Present at the SVB Securities Global Biopharma Conference, from 3 hours ago by GlobeNewswire
3 hours ago by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vaxcyte Inc | 3.6B | -15.4x | --- |
Intellia Therapeutics Inc | 3.6B | -7.6x | --- |
Immunocore Holdings PLC | 2.9B | -40.4x | --- |
Beam Therapeutics Inc | 3.4B | -10.5x | --- |
IVERIC bio Inc | 3.1B | -17.0x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,295.8x | --- |
Company Information
Vaxcyte Inc. is a clinical-stage vaccine company focused on developing vaccines to protect humankind from the consequences of bacterial diseases. The Company’s pipeline includes pneumococcal conjugate vaccine (PCV), VAX-24, VAX-XP, VAX-A1 and VAX-PG. The Company’s PCV candidates is in development, targeting global pneumococcal vaccine market. The Company’s lead vaccine candidate, VAX-24, is a 24-valent, broad-spectrum investigational PCV being developed for the prevention of invasive pneumococcal disease (IPD) and pneumonia. The Company’s PCV candidate, VAX-XP, leverages its scalable and modular platform and builds on the technical proof-of-concept established by VAX-24. VAX-A1 is a novel conjugate vaccine candidate designed to prevent Group A Strep pervasive disease. VAX-PG is a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis and chronic oral inflammatory disease.
Contact Information
- Headquarters
- 825 INDUSTRIAL ROAD, STE. 300SAN CARLOS, CA, United States 94070
- Phone
- 650-837-0111
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Carlos Paya
- Chief Financial Officer
- Andrew Guggenhime
- Chief Executive Officer, Co-Founder, Director
- Grant Pickering
- Co-Founder, Vice President - Research
- Jeff Fairman
- Chief Operating Officer, Executive Vice President
- Jim Wassil
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.6B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 79.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.95 |
Book Value | $5.36 |
P/E Ratio | -15.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
